SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-014563
Filing Date
2018-05-31
Accepted
2018-05-31 17:13:47
Documents
1
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3457
  Complete submission text file 0000899243-18-014563.txt   5007
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8
Business Address
Wechsler Daniel Mark (Reporting) CIK: 0001582285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 18872552